Sukses Main Mahjong Ways Best808 Pahami Scatter dan Kombinasinya Mahjong Ways Best808 Simbol Scatter Meningkatkan Peluang Menang Kesalahan Umum Pemain Mahjong Ways di Best808 Auto Jackpot Strategi Terbaik Fitur Scatter Mahjong Ways Best808 Mahjong Ways Best808 Panduan Scatter Wild Hasil Maksimal Pola Mahjong Ways Best808 Gacor Scatter Menang Bongkar Misteri Mahjong Ways Best808 Kunci Kemenanganmu Mau Cuan Maksimal di Mahjong Ways Best808 Trik Menggunakan Scatter Agar Lebih Untung Main Mahjong Ways di Best808 Kenali Pola Scatter Free Spin Gandakan Kemenanganmu Rahasia Scatter Mahjong Ways Best808 Strategi Jitu Menang Jackpot Besar Misteri Scatter Mahjong Ways Tol777 Kunci Jackpot Besar Bongkar Rahasia Mahjong Ways Tol777 Fitur Scatter Pola Menang Mahjong Ways Tol777 Simbol Scatter Kemenangan Besar Main Mahjong Ways di Tol777 Cara Memanfaatkan Scatter Strategi Mahjong Ways Tol777 Rahasia Scatter Trik Menang Jackpot Analisis Pola Permainan Mahjong Ways Keunggulan Mahjong Ways Tol777 vs Tradisional Kombinasi Simbol Tertinggi Mahjong Ways Langkah Meningkatkan Keahlian Mahjong Ways Mahjong Ways Tol777 Berbeda dari Permainan Mengapa Mahjong Ways Tol777 Diminati Dunia Optimalkan Putaran Mahjong Ways Tol777 Sejarah Mahjong Ways Tol777 dan Keunikan Simbol Mahjong Ways Tol777 dan Pemanfaatannya Strategi Lanjutan Mahjong Ways Tol777 Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Live RTP Dan Kasino Online Cara Cepat Kuasai Mahjong Ways Tol777 Mengapa Mahjong Ways Tol777 Populer Mitos & Fakta Mahjong Ways Tol777 Strategi Pemula vs Pro Mahjong Ways Teknik Profesional Mahjong Ways Tol777 Mahjong Ways Tol777: Keberuntungan atau Skill? Mahjong Ways Tol777: Tradisi dan Inovasi Panduan Mahjong Ways Tol777 untuk Pemula Rahasia Menang Mahjong Ways Tol777 Tips Efektif Main Mahjong Ways Tol777 Kasino Online Kasino Online Kasino Online Kasino Online Kasino Online Kasino Online Kasino Online Kasino Online Kasino Online Kasino Online main mahjong ways di malam hari jackpot profit mengamati permainan mahjong ways dengan baik dan benar merasa bosan pada malam hari? coba cara bermain mahjong ways ini minum kopi memotivasi bermain mahjong ways nelayan tebing tinggi pola mahjong ways hasil mencengangkan pelajar bandung download mahjong ways peluang besar trik dan pola mahjong ways pemuda belanda tato mahjong ways mengenang jackpot satu miliar pola rtp mahjong ways terbaik resep bermain mahjong ways dengan mudah slot mahjong ways dikenal sejak abad ke-11 hingga zaman milenial video mahjong ways viral menghebohkan warga indonesia warga jayamakmur dulu diremehkan, bermain mahjong ways hidup berlimpah harta unik keren bali cendera mata mahjong ways rp100000 warga bingung merek cat dinding sama mahjong ways

Rising Regulatory Burdens, Declining Health Outcomes

Tweaks do not turn bad regulatory proposals into good ones. Yet, with only minor modifications, Congress is once again considering the CREATES Act (Creating and Restoring Equal Access to Equivalent Samples Act of 2017), and its close cousin, the FAST Act (Fair Access for Safe and Timely Generics Act of 2017).

Regulatory analyses quickly become detailed, and, frankly, quite boring. However, as the size and scope of the regulatory burden continues to grow, so does the negative impact on our economic well-being.

In a comprehensive study that examined the economic impact from federal regulations, the Mercatus Center estimated that, as of 2012, Americans were poorer by $13,000 per person due to the lost potential income that the growing regulatory burden has caused. These estimates imply that the income for a household of four could have been double what it is today if not for overly burdensome federal regulations.

What is true for the entire economy, is also true for the health care sector. The health care sector suffers from burdensome regulatory burdens, excessive litigation costs, and innovation-inhibiting incentives. Improving the health care sector’s outcomes require reforms that streamline the regulatory burden, reduce litigation costs, and increase the incentives for innovation.

If implemented, the CREATES Act will do just the opposite. To understand why, some background on the minutiae of pharmaceutical regulations is necessary.

The risks associated with pharmaceuticals vary. For some drugs, the risks of side effects are high necessitating special requirements. For some of these medications, the requirements are relatively simple; for instance, additional labeling instructions. For others, the requirements are more involved; such as, requiring specific training for health professionals when dispensing the drug, requiring the drug to be dispensed in the hospital, and/or requiring monitoring of patients who are using the drug.

The CREATES and FAST Acts impact these drugs with the most comprehensive safety requirements. These requirements are also known as “risk evaluation and mitigation strategies” (REMS); and may be subject to restrictions called “elements to assure safe use” (ETASU).

The REMS frameworks are developed by the FDA working with the branded manufacturers. They are designed to balance out the higher risks associated with these medicines with the value they provide patients with life threatening illnesses.

The drugs that are subject to the REMS standards (and the REMS with ETASU standards) are subject to rigorous processes to safeguard patients against severe, or even fatal, consequences. Existing regulations also contain processes that enable generic manufacturers to purchase the necessary samples of REMS drugs so that generic companies can test their products and introduce a generic competitor to the branded drug once its patent has expired.

Despite these provisions, generic manufacturers raise objections, alleging that branded manufacturers use the REMS and REMS with ETASU requirements to avoid selling samples to generic manufacturers. The CREATES and FAST Acts attempt to turn these objections into legislative action.

These Acts are cures looking for ills, however. Worse, these Acts create new problems that far outweigh the benefit these bills are supposed to create.

Both Acts empower more litigation by requiring brand named pharmaceutical companies to conclude what can be a very complicated negotiation process, and turn over the required samples to generic manufacturers, within 31 days after the initial request was made, or be subject to costly lawsuits.

Due to the lawsuit threat, generic manufacturers would no longer need to negotiate with the branded manufacturers in good faith – they could simply let the threat of a lawsuit do the negotiating for them.

This ticking clock problem jeopardizes patient safety by increasing the likelihood that the people administering these potent drugs may lack the appropriate training and knowledge to do so safely. Patient welfare could also be impacted by forcing branded manufacturers to divert drugs in short supply from patients to generic manufacturers, thereby exacerbating any potential shortage problems.

Branded manufacturers could also face increased litigation risk caused by the actions of third parties who may be hired by the generic manufacturer. These increased litigation risks raise the overall costs on branded manufacturers, and diminish the incentives to further innovate.

The CREATES and FAST Acts represent the wrong type of regulatory reforms. Instead of expanding regulations and incenting greater litigation, effective health care reforms need to incent innovation in the practice of medicine and increase patients control over their own personal health care decisions.

The CREATES and FAST Acts are distractions from these beneficial health care reforms. By clogging up the Congressional calendar, they make it more difficult to consider beneficial health care reforms that would effectively improve overall patient well-being. And, perhaps, these lost reform opportunities are the costliest aspects of all.

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Scroll to Top